ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 230 filers reported holding ICU MED INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $258,000 | -25.4% | 1,662 | -1.5% | 0.00% | 0.0% |
Q2 2021 | $346,000 | -1.7% | 1,687 | -1.5% | 0.00% | 0.0% |
Q1 2021 | $352,000 | -13.9% | 1,713 | -10.0% | 0.00% | -50.0% |
Q4 2020 | $409,000 | +2.5% | 1,904 | -12.9% | 0.00% | 0.0% |
Q3 2020 | $399,000 | -31.2% | 2,186 | -30.9% | 0.00% | -33.3% |
Q2 2020 | $580,000 | +11.5% | 3,163 | +22.6% | 0.00% | 0.0% |
Q1 2020 | $520,000 | +39.8% | 2,579 | +29.4% | 0.00% | +50.0% |
Q4 2019 | $372,000 | +22.0% | 1,993 | +4.8% | 0.00% | 0.0% |
Q3 2019 | $305,000 | -34.5% | 1,902 | +4.2% | 0.00% | -33.3% |
Q2 2019 | $466,000 | +37.5% | 1,825 | +28.5% | 0.00% | +50.0% |
Q1 2019 | $339,000 | +15.3% | 1,420 | +10.9% | 0.00% | 0.0% |
Q4 2018 | $294,000 | -2.0% | 1,281 | +20.3% | 0.00% | 0.0% |
Q3 2018 | $300,000 | -57.9% | 1,065 | -56.2% | 0.00% | -66.7% |
Q2 2018 | $713,000 | +124.9% | 2,432 | +94.1% | 0.01% | +100.0% |
Q1 2018 | $317,000 | +32.6% | 1,253 | +13.2% | 0.00% | +50.0% |
Q4 2017 | $239,000 | +13.8% | 1,107 | -2.2% | 0.00% | 0.0% |
Q3 2017 | $210,000 | – | 1,132 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EVR Research LP | 22,000 | $4,719,000 | 3.86% |
NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |